Regenerative Medicine and Stem cell based Cell therapies-Drugs of the Future Offering Hope for Cure

THERAPEUTIC CLASS OVERVIEW

Therapeutic Class Overview : Regenerative Medicines

Reg

nera

tive

Med

icin

es

REGENERATIVE MEDECINE

Reg

nera

tive

Med

icin

es

Table of Contents

Therapeutic Class Overview : Regenerative Medicines

Regenerative Medicines /01

Reg

nera

tive

Med

icin

es

Regenerative Medicine and Stem cell based Cell therapies-Drugs of the Future Offering Hope for Cure

• EXECUTIVE SUMMARY

• INTRODUCTION

• Tough Choice- “Autologous vs. Allogenic " Therapies

• REGULATORY GUIDELINES

• Marketed Cell based/Stem Cell Products

• Progress and Challenges

• Progress in Specific Therapy Areas

• SELECT UPCOMING MILESTONES IN REGENERATIVE MEDICINE/STEM CELL FOCUSED COMPANIES (2015-16)

• Appendix

• Merger and Acquisition- Gaining Momentum in Regenerative Space

– Dawn of the Golden Era for Regenerative Medicine/Stem cell based therapies

– Stem cells Types – Mesenchymal stem cells (MSCs)

– Japan and Asia Lead the Way – Japanese Adaptive Licensing Legislation – South Korea Regulatory Update – India Regulatory Update – Regulatory Scenario in US and EU

– Diabetes – Cardiovascular Disease – Musculoskeletal (MSD) Related Conditions – Ocular Disease

– Approved Cell-based / Stem Cell Therapies in Korea and WW – Cost of Treatment of Approved Therapies

– Reimbursement of Approved Cell based Therapies!

Table Of Contents : Regenerative Medicines /01